XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Convertible Preferred Stock and Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Warrants to Placement Agent
Convertible Preferred Stock
Common Stock
Non-voting Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 5,585 [1] $ 2,824 $ (22,420) $ (19,596)
Balance (in Shares) at Dec. 31, 2021 [2]   773,108 205,040 178,377      
Exercise of options into common stock [1]   [1]   [1]
Exercise of options into common stock (in Shares) [2]   1,546      
Share based compensation     14   14
Share based compensation (in Shares) [2]          
Net comprehensive loss for the period     (4,639) (4,639)
Net comprehensive loss for the period (in Shares) [2]          
Balance at Mar. 31, 2022 $ 5,585 [1] 2,838 (27,059) (24,221)
Balance (in Shares) at Mar. 31, 2022 [2]   773,108 206,586 178,377      
Balance at Dec. 31, 2021 $ 5,585 [1] 2,824 (22,420) (19,596)
Balance (in Shares) at Dec. 31, 2021 [2]   773,108 205,040 178,377      
Net comprehensive loss for the period             (6,293)
Balance at Jun. 30, 2022 $ 1 36,469 (28,713) 7,757
Balance (in Shares) at Jun. 30, 2022 [2]   1,731,755      
Balance at Mar. 31, 2022 $ 5,585 [1] 2,838 (27,059) (24,221)
Balance (in Shares) at Mar. 31, 2022 [2]   773,108 206,586 178,377      
Share based compensation 14 14
Share based compensation (in Shares) [2]        
Conversion of convertible preferred stock to common stock upon initial public offering $ (5,585) $ 1 5,584 5,585
Conversion of convertible preferred stock to common stock upon initial public offering (in Shares) [2]   (773,108) 773,108      
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs [1] 14,675 14,675
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions and other offering costs (in Shares) [2]   421,250      
Conversion of convertible loan to common stock upon initial public offering [1] 6,553 6,553
Conversion of convertible loan to common stock upon initial public offering (in Shares) [2]   163,816      
Conversion of convertible note to common stock upon initial public offering [1] 3,600 3,600
Conversion of convertible note to common stock upon initial public offering (in Shares) [2]   90,009      
Conversion of warrants to common stock upon initial public offering [1] 3,190 3,190
Conversion of warrants to common stock upon initial public offering (in Shares) [2]   79,756      
Redemption of non-voting common stock upon initial public offering [1]
Redemption of non-voting common stock upon initial public offering (in Shares) [2]   (178,377)      
Repurchase of common stock [1] 15 15
Repurchase of common stock (in Shares) [2]   (2,770)      
Net comprehensive loss for the period (1,654) (1,654)
Net comprehensive loss for the period (in Shares) [2]        
Balance at Jun. 30, 2022 $ 1 36,469 (28,713) 7,757
Balance (in Shares) at Jun. 30, 2022 [2]   1,731,755      
Balance at Dec. 31, 2022 $ 1 36,666 (33,402) 3,265 [3]
Balance (in Shares) at Dec. 31, 2022   [2] 1,737,986 [2]      
Share based compensation 95 95
Share based compensation (in Shares) [2]          
Repurchase of common stock [1] (50) (50)
Repurchase of common stock (in Shares)   [2] (7,920) [2]      
Net comprehensive loss for the period (1,895) (1,895)
Net comprehensive loss for the period (in Shares) [2]          
Balance at Mar. 31, 2023 $ 1 36,711 (35,297) 1,415
Balance (in Shares) at Mar. 31, 2023   [2] 1,730,066 [2]      
Balance at Dec. 31, 2022 $ 1 36,666 (33,402) $ 3,265 [3]
Balance (in Shares) at Dec. 31, 2022   [2] 1,737,986 [2]      
Redemption of non-voting common stock upon initial public offering (in Shares)             178,377
Net comprehensive loss for the period             $ (3,488)
Balance at Jun. 30, 2023 104 $ 1 38,174 (36,890) 1,285 [3]
Balance (in Shares) at Jun. 30, 2023   [2] 1,930,718 [2]      
Balance at Mar. 31, 2023 $ 1 36,711 (35,297) 1,415
Balance (in Shares) at Mar. 31, 2023   [2] 1,730,066 [2]      
Exercise of options into common stock [1] 10 10
Exercise of options into common stock (in Shares)   [2] 10,652 [2]      
Share based compensation   97 97
Share based compensation (in Shares) [2]          
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs 104 [1] 1,356 1,356
Issuance of common stock and pre-funded warrants upon private placement, net of underwriting commissions and other offering costs (in Shares)   [2] 190,000 [2]      
Net comprehensive loss for the period (1,593) (1,593)
Net comprehensive loss for the period (in Shares) [2]          
Balance at Jun. 30, 2023 $ 104 $ 1 $ 38,174 $ (36,890) $ 1,285 [3]
Balance (in Shares) at Jun. 30, 2023   [2] 1,930,718 [2]      
[1] Represents an amount less than $1 thousands.
[2] Adjusted to reflect reverse stock split, see note 3(f).
[3] Adjusted to reflect reverse stock split, see note 3(f).